Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Injection vs Celecoxib in TKA
NCT05324995Phase 2Completed
- Start
- Jan 2021
- Primary completion
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine, morphine, epinephrine and ketorolac in postoperative pain (3 arms). Primary endpoints: Knee Society Score at 6 months, Range of Motion at 6 months and 1 more. Started Jan 2021; status: completed.
02
Drugs
bupivacainemorphineepinephrineketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05324995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05324995.